Index

The Science of Testing on Dogs

Every year, tens of thousands of beagles are born into a system designed to use them as biological instruments — tested, measured, and killed in the service of pharmaceutical development. This section examines the science behind that system.

The beagle is not in the laboratory by accident. A convergence of biological traits, regulatory history, and economic logic locked this breed into pharmaceutical testing beginning in the 1950s. Today, beagles account for over 97% of all dogs used in scientific procedures — a dominance unmatched by any other breed in any other field of research.

What follows is a structured examination of four dimensions of this system: the animal itself — its biology, genetics, and psychology; the procedures — what is physically done to the dogs and why; the lifecycle — how a beagle's life unfolds from birth at a breeding facility to death on a necropsy table; and the alternatives — what technologies exist to replace animal testing and why adoption has been so slow.

The science is not in dispute. The procedures are documented. The numbers are reported annually by the USDA. What is in dispute is whether the system is justified — and whether it can be changed fast enough to matter for the dogs inside it right now.

42,880
dogs in US labs
FY2024
Source: USDA APHIS
97.3%
are beagles
UK data
Source: Home Office
1–3 yrs
lab beagle lifespan
Normal: 12–15
95%+
euthanized after studies
Regulatory necropsy required
Key Finding
The traits that make beagles beloved pets — gentle, trusting, social, eager to please — are precisely why they were selected for laboratory use. They don't fight back. They tolerate procedures that would provoke aggression in other breeds. Their docility is their vulnerability.

The Six Converging Traits

Six traits converged to make the beagle the pharmaceutical industry's default test animal. Each one is a feature of the breed repurposed as a laboratory advantage. Click any trait to see how it manifests in practice.

Related Reading